fda declares semaglutide shortage resolved february 2025 ends as sets deadline for compounders The GLP-1 drug shortage is

People should not use Wegovy if they have: a personal or family history of medullary thyroid cancer multiple Endocrine Neoplasia Syndrome 2 a high risk of pancreatitis severe allergic reactions to semaglutide or other ingredients in Wegovy Learn more: Wegovy side effects: What you should know

Improved Sleep & Cognitive Function Growth hormone (GH) secretion increases during deep sleep as part of normal physiology

This is a benefit exclusion: no prior authorization will override it on an excluded fully insured plan, and a medical-necessity appeal will not succeed where the drug is categorically excluded from covered benefits

Early water weight loss can be encouraging but shouldnt be mistaken for the sustained fat loss that comes later